AMRNAmarin Corporation plc

14.09USDMkt Cap: 295.45M $P/E:

Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers…

Key Statistics

Company
Market Cap295.45M $
Enterprise Value-9.85M $
Revenue (TTM)186.23M $
Gross Profit120.87M $
Net Income (TTM)-38.80M $
Revenue/Share8.917 USD
Last Price14.09 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees80
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS0231112063
Valuation
P/E (Trailing)
P/E (Forward)14.38
PEG0.81
EV/EBITDA0.47
EV/Revenue-0.05
P/S1.60
P/B0.67
EPS (TTM)-1.20
EPS (Forward)0.98
52W Range
14.0234% of range14.22
52W High14.22 USD
52W Low14.02 USD
Profitability
Gross Margin56.57%
Oper. Margin-28.36%
EBITDA Margin-11.33%
Profit Margin-18.16%
ROE-8.45%
ROA-5.78%
Growth
Revenue Growth-42.00%
Earnings Growth
Cash Flow & Leverage
Operating CF6.73M $
CapEx (TTM)
FCF Margin-2.99%
FCF Yield-1.88%
Net Debt-307.47M $
Net Debt/EBITDA14.58
Balance Sheet
Debt/Equity0.01
Current Ratio3.67
Quick Ratio2.49
Book Value/Sh21.12 USD
Cash/Share14.90 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:20
Split DateApr 11, 2025
Analyst Consensus
Rating4.5 (Sell)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)12.50 USD
Upside (mean)-11.3%
Target Range12.00 USD13.00 USD
$12.00-11.3% to mean$13.00
# Analysts2
Ownership
Shares Out.20.97M
Float19.03M
Insiders37.17%
Institutions22.49%
Short Interest
Short Ratio7.9d
Short % Float2.57%
Short % Out.2.52%
Shares Short532.11K
Short (prev mo.)542.86K
Technical
SMA 5014.74 (-4.4%)
SMA 20014.84 (-5.1%)
Beta0.77
S&P 52W Chg19.18%
Avg Vol (30d)36.55K
Avg Vol (10d)46.91K
Technical Indicators
RSI (14)45.8
MACD-0.1071
MACD Signal-0.1416
MACD Hist.+0.0345
BB Upper14.47 USD
BB Middle14.15 USD
BB Lower13.83 USD
BB Width4.50%
ATR (14)0.4153 USD
Vol Ratio (20d)0.71x